3 questions to. . . Dr. med. Bernhard Gibis, KBV Head of Department
The KBV contract workshop has developed around dozen contracts since 2005. Why are the health insurers not taking action?
Answer: It is still not worthwhile for you to invest in cost-intensive, improved care. The risk seems too great to them that certain offers will attract patients with high risks and costs. But it is always said: In the long term, good care pays off.
Answer: This is not an argument for health insurers that can become insolvent and that do not know how much money they will get from the risk structure compensation in the long term. In addition, the benefits of better care often amortize in other areas. And the patient can change cash registers at any time. The probability that cash register will benefit from the success of one of its measures is initially relatively low. How do you then convince health insurances of the contracted workshop?
Answer: By finding constructive insurances that care about care. One example is the ADHD contract with the company health insurance funds in Baden-Wrttemberg. We are currently negotiating rheumatism contracts with various local health insurers. We have put together package for them: discount agreements, improved rheumatism management, better access to care. The drugs are very expensive. We presented an evidence-based step-by-step plan for the regulations that is recognized, even if not every pharmaceutical company complies with it.